Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.226
Buy
RSI(14)
62.168
Neutral
STOCH(KDJ)(9,3,3)
72.401
Neutral
ATR(14)
0.432
High Vlolatility
CCI(14)
103.699
Buy
Williams %R
11.055
Overbought
TRIX(12,20)
0.567
Sell
StochRSI(14)
87.355
Buy
Search
Senseonics Holdings Inc
SENSAdd to Watchlist
7.417USD
+0.165+2.27%
Market hours （ET）Quotes delayed by 15 min
309.98MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Senseonics Holdings Inc
Currency: USD Updated: 2026-06-08Key Insights
Senseonics Holdings Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 99 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 13.80.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Senseonics Holdings Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Senseonics Holdings Inc Highlights
StrengthsRisks
Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems Eversense 365 and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. Its CGM systems are indicated for continually measuring glucose levels for up to 365 days for Eversense 365 and 180 days for Eversense E3 in persons with diabetes age 18 and older. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 57.47% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 35.26M.
Fairly Valued
The company’s latest PE is -3.62, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 8.74M shares, increasing 15.31% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 50.00 shares of this stock.
Analyst Rating
Based on
7
analysts
Hold
Current Rating
13.800
Target Price
+129.24%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-06-08The current financial score of Senseonics Holdings Inc is 6.09, ranking 176 out of 204 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 11.71M, representing a year-over-year increase of 87.17%, while its net profit experienced a year-over-year increase of 126.76%.
Score
Financials
6.32
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
7.72
Operational Efficiency
2.81
Growth Potential
6.48
Shareholder Returns
7.13
Senseonics Holdings Inc's Company Valuation
Currency: USD Updated: 2026-06-08The current valuation score of Senseonics Holdings Inc is 7.07, ranking 126 out of 204 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -3.62, which is -312.59% below the recent high of 7.70 and -2269.20% above the recent low of -85.77.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 99/204
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-06-08The current earnings forecast score of Senseonics Holdings Inc is 7.00, ranking 156 out of 204 in the Healthcare Equipment & Supplies industry. The average price target is 19.25, with a high of 31.00 and a low of 9.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
7
analysts
Hold
Current Rating
13.800
Target Price
+129.24%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Senseonics Holdings Inc
SENS
7
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Stryker Corp
SYK
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-06-08The current price momentum score of Senseonics Holdings Inc is 9.78, ranking 1 out of 204 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 7.99 and the support level at 5.64, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
6.880
Buy
MA10
6.750
Buy
MA20
6.271
Buy
MA50
6.374
Buy
MA100
6.758
Buy
MA200
7.142
Buy
Institutional Confidence
Currency: USD Updated: 2026-06-08The current institutional shareholding score of Senseonics Holdings Inc is 3.00, ranking 133 out of 204 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 20.91%, representing a quarter-over-quarter increase of 32.16%. The largest institutional shareholder is PRFDX, holding a total of 18.90K shares, representing 0.05% of shares outstanding, with 1.00% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2026-06-08The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Senseonics Holdings Inc is 3.38, ranking 125 out of 204 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.05. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.
Score
Beta vs S&P 500 index
1.05
VaR
+7.74%
240-Day Maximum Drawdown
+57.19%
240-Day Volatility
+80.39%
Return
Best Daily Return
60 days
+14.71%
120 days
+14.71%
5 years
+80.62%
Worst Daily Return
60 days
-22.84%
120 days
-22.84%
5 years
-33.70%
Sharpe Ratio
60 days
+1.43
120 days
+0.43
5 years
-0.12
Risk Assessment
Maximum Drawdown
240 days
+57.19%
3 years
+72.73%
5 years
+93.72%
Return-to-Drawdown Ratio
240 days
-0.51
3 years
+3.18
5 years
+0.20
Skewness
240 days
-0.32
3 years
+4.01
5 years
+2.66
Volatility
Realised Volatility
240 days
+80.39%
5 years
+163.23%
Standardised True Range
240 days
+7.11%
5 years
+2.61%
Downside Risk-Adjusted Return
120 days
+49.55%
240 days
+49.55%
Maximum Daily Upside Volatility
60 days
+72.73%
Maximum Daily Downside Volatility
60 days
+61.10%
Liquidity
Average Turnover Rate
60 days
+0.09%
120 days
+0.07%
5 years
--
Turnover Deviation
20 days
-86.29%
60 days
-89.09%
120 days
-90.63%
Peer Comparison
Healthcare Equipment & Supplies
Senseonics Holdings Inc
SENS
6.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
COR
8.71 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
EW
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Repligen Corp
RGEN
8.52 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
TMO
8.40 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
